Financial statements Eubioco1
Balance sheet data of EUBIOCO1
|
Year
|
2017
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 127 055 699,98 | 125 911 242,91 | 127 132 697,32 | 124 914 921,85 | 125 418 978,87 |
| A. Fixed assets | 123 496 191,83 | 124 006 804,80 | 123 959 681,56 | 124 101 018,46 | 124 278 027,88 |
| B. Current assets | 3 559 508,15 | 1 904 438,11 | 3 173 015,76 | 813 903,39 | 1 140 950,99 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 127 055 699,98 | 125 911 242,91 | 127 132 697,32 | 124 914 921,85 | 125 418 978,87 |
| A. Equity | -2 895 168,05 | -3 098 193,48 | -2 531 945,72 | -2 320 698,07 | -2 082 669,72 |
| B. Liabilities and provisions for liabilities | 129 950 868,03 | 129 009 436,39 | 129 664 643,04 | 127 235 619,92 | 127 501 648,59 |
| I. Long-term liabilities | 97 233 298,99 | 95 693 566,83 | 93 810 763,87 | 90 384 140,19 | 96 422 810,87 |
| II. Short-term liabilities | 5 981 799,37 | 7 426 448,55 | 10 916 265,61 | 12 668 674,50 | 7 584 927,15 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.